Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tomiko Kimoto"'
Autor:
Tomohiro Morio, Tsubasa Okano, Yujin Sekinaka, Eri Endo, Katsuyuki Hanabusa, Ikuya Tsuge, Shiann Tarng Jou, Masataka Ishimura, Hsin-Hui Yu, Yoshihiro Maruo, Tomiko Kimoto, Tomoaki Kunitsu, Hiroshi Yagasaki, Masami Inoue, Kenichi Yoshida, Yuki Tsujita, Taizo Wada, Kohsuke Imai, Kyoko Suzuki, Seiji Kojima, Sven Kracker, Tetsuzo Tauchi, Yuko Hashimoto, Takehiro Takashima, Yuzaburo Inoue, Toru Uchiyama, Hidetoshi Takada, Kenichi Honma, Motohiro Kato, Masakazu Nagahori, Takashi Kaneko, Yoshiaki Shikama, Naohiko Moriguchi, Tomoko Waragai, Daiei Kojima, Haruka Hiroki, Tamaki Kato, Kanako Mitsui-Sekinaka, Keisuke Tanaka, Anne Durandy, Yuki Bando, Hideki Muramatsu, Kazuhiro Tasaki, Seishi Ogawa, Hirokazu Kanegane, Fuminori Iwasaki, Shigeaki Nonoyama, Tzu Wen Yeh, Chikako Kamae, Toshihiko Shirakawa, Osamu Suzuki, Tomoyo Matsubara, Hideki Sano, Yuki Yuza, Osamu Ohara, Noriko Mitsuiki
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:266-275
Background Activated phosphatidylinositol-3-OH kinase δ syndrome type 1 (APDS1) is a recently described primary immunodeficiency syndrome characterized by recurrent respiratory tract infections, lymphoid hyperplasia, and Herpesviridae infections cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bb44153e5e8d631309e74864a023dc5
https://doi.org/10.1016/j.jaci.2018.04.032
https://doi.org/10.1016/j.jaci.2018.04.032
Autor:
Sadao Tokimasa, Kanako Isaka, Kayo Yamada, Akihisa Sawada, Masami Inoue, Keisei Kawa, Hiroaki Kikuchi, Mariko Shimizu, Maho Koyama-Sato, Osamu Kondo, Masahiro Yasui, Tomiko Kimoto
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2):214-221
Chronic Epstein-Barr virus–associated T/natural killer cell lymphoproliferative diseases represented by chronic active Epstein-Barr virus infection are lethal but are curable with several courses of chemotherapy and allogeneic hematopoietic stem ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99381ac26a67be0b9130f529330ba4a9
Autor:
Hajime Hosoi, Tomiko Kimoto, Keisei Kawa, Masami Inoue, Tomoko Iehara, Sadao Tokimasa, Shigeki Yagyu
Publikováno v:
Pediatric Blood & Cancer. 56:865-867
We present the case of a 1-year-old female with stage-4 neuroblastoma with MYCN amplification; she was treated with five chemotherapy courses, resulting in normalization of elevated serum levels of tumor markers. Complete remission was achieved after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::951316307d0ca6fbe8455ca06a91fcbe
https://doi.org/10.1002/pbc.22925
https://doi.org/10.1002/pbc.22925
Autor:
Tomiko, Kimoto, Masami, Inoue, Sadao, Tokimasa, Shigeki, Yagyu, Tomoko, Iehara, Hajime, Hosoi, Keisei, Kawa
Publikováno v:
Pediatric bloodcancer. 56(5)
We present the case of a 1-year-old female with stage-4 neuroblastoma with MYCN amplification; she was treated with five chemotherapy courses, resulting in normalization of elevated serum levels of tumor markers. Complete remission was achieved after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::604e7e97a93fc2969f7d3a89b08b6cbe
https://pubmed.ncbi.nlm.nih.gov/21370425
https://pubmed.ncbi.nlm.nih.gov/21370425
Publikováno v:
International Journal of Hematology. 89:251-252
Imatinib is an inhibitor of tyrosine kinase as well as BCRABL, platelet-derived growth factor receptor (PDGF-R) and c-kit, and is becoming a first-line treatment for chronic myeloid leukemia (CML). In children, the long-term toxic effects related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44ba8ec03625498a38dfe35ab63fdc96
https://doi.org/10.1007/s12185-008-0251-8
https://doi.org/10.1007/s12185-008-0251-8
Autor:
Maho Satou, Hideaki Ohta, Osamu Kondou, Masami Inoue, Masahiro Yasui, Tomiko Kimoto, Sadao Tokimasa, Kayo Yamada, Keisei Kawa
Publikováno v:
Blood. 114:1161-1161
Abstract 1161 Poster Board I-183 Introduction The number of cord blood transplantation (CBT) is rapidly increasing. In this setting, development of Epstein-Barr virus (EBV)-associated lymphoproliferative disorder (LPD) appears to be at high risk. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73e7b6cb39d60627435c94a1c5ebfcc5
https://doi.org/10.1182/blood.v114.22.1161.1161
https://doi.org/10.1182/blood.v114.22.1161.1161